Antibody to Capsular Polysaccharides of Streptococcus pneumoniae: Prevalence, Persistence, and Response to Revaccination
about
Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisationNonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia.Rethinking recommendations for use of pneumococcal vaccines in adults.Pneumococcal polysaccharide abrogates conjugate-induced germinal center reaction and depletes antibody secreting cell pool, causing hyporesponsiveness.Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue.Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response.Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus.Pneumococcal virulence factors and host immune responses to them.Reimmunization with 23-valent pneumococcal vaccine for patients infected with human immunodeficiency virus type 1: clinical, immunologic, and virologic responses.Risk factor analysis for pneumococcal meningitis in adults with invasive pneumococcal infection.Polysaccharide vaccines: determinants of clinical efficacy.Gram-Positive Pneumonia.
P2860
Q24809188-04A420AB-7712-4864-B218-B775D6EEEE78Q28744146-603A70A3-CB33-4223-932F-DB9F0274B0E3Q33181645-0884C84C-34FD-4C2A-8110-99BE0FE7AB72Q34326459-C37CCCAD-6E44-4C0E-BFA2-30D14FFB9185Q34998490-5B8B9935-3FDE-4147-BED3-017EA9A994E6Q35586932-A2883946-23C0-4B0D-AE1C-0B7CFFF175D5Q36009704-B0875EDA-FB7E-434F-983C-5B8929C049A9Q37461377-018C2B85-BFAF-4354-AC05-32BE703DE73EQ37857246-7AC5F89A-1CEC-475E-827D-705689D79447Q38494482-877C6E70-60F4-4BFD-BCCA-D79E66FE7511Q40432501-7E2FC4A6-80AA-48CE-9610-81BF372475C1Q40588212-75A1C93D-154C-4F77-947C-8CC9D1B85268Q44119586-AD91CE55-FBAC-4B7F-A903-EDB42D4B92A5Q53590174-4D2C480E-76E7-46A6-9ED6-CC22A8B0A6ACQ54028638-6084E884-33F4-43BB-9488-36C29E62557D
P2860
Antibody to Capsular Polysaccharides of Streptococcus pneumoniae: Prevalence, Persistence, and Response to Revaccination
description
article
@en
im Juli 1993 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1993
@uk
name
Antibody to Capsular Polysacch ...... and Response to Revaccination
@en
Antibody to Capsular Polysacch ...... and Response to Revaccination
@nl
type
label
Antibody to Capsular Polysacch ...... and Response to Revaccination
@en
Antibody to Capsular Polysacch ...... and Response to Revaccination
@nl
prefLabel
Antibody to Capsular Polysacch ...... and Response to Revaccination
@en
Antibody to Capsular Polysacch ...... and Response to Revaccination
@nl
P2093
P356
P1476
Antibody to capsular polysacch ...... and response to revaccination
@en
P2093
D A Watson
D M Musher
J E Groover
J M Rowland
M A Mufson
R E Baughn
P356
10.1093/CLINIDS/17.1.66
P407
P50
P577
1993-07-01T00:00:00Z